Your browser doesn't support javascript.
loading
Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols.
Khan, Tahira; Stewart, Mark; Blackman, Samuel; Rousseau, Raphaël; Donoghue, Martha; Cohen, Kenneth; Seibel, Nita; Fleury, Mark; Benettaib, Bouchra; Malik, Raleigh; Vassal, Gilles; Reaman, Gregory.
Affiliation
  • Khan T; 1 Genentech Inc, a member of the Roche Group, South San Francisco, CA, USA.
  • Stewart M; 2 Friends of Cancer Research, Washington, DC, USA.
  • Blackman S; 3 Silverback Therapeutics, Seattle, WA, USA.
  • Rousseau R; 1 Genentech Inc, a member of the Roche Group, South San Francisco, CA, USA.
  • Donoghue M; 4 Food and Drug Administration, Silver Spring, MD, USA.
  • Cohen K; 5 Department of Pediatrics and Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
  • Seibel N; 6 USA National Cancer Institute, Bethesda, MD, USA.
  • Fleury M; 7 American Cancer Society Cancer Action Network Inc, Washington, DC, USA.
  • Benettaib B; 8 Celgene Corporation, Summit, NJ, USA.
  • Malik R; 9 Drug Information Association, Washington, DC, USA.
  • Vassal G; 10 Department of Clinical Research, Institut Gustave Roussy, Paris-Sud University, Paris, France.
  • Reaman G; 4 Food and Drug Administration, Silver Spring, MD, USA.
Ther Innov Regul Sci ; 53(2): 270-278, 2019 03.
Article in En | MEDLINE | ID: mdl-29759018
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Protocols / Clinical Trials as Topic / Drug Development / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Child / Humans Language: En Journal: Ther Innov Regul Sci Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Protocols / Clinical Trials as Topic / Drug Development / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Child / Humans Language: En Journal: Ther Innov Regul Sci Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza